References
- Anderson GD. (2005). Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 14:19–29
- Asaoka Y, Sakai H, Sasaki J, et al. (2010). Changes in the gene expression and enzyme activity of hepatic cytochrome P450 in juvenile Sprague-Dawley rats. J Vet Med Sci 72:471–9
- Boogaard PJ, Sumner SC, Bond JA. (1996). Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicol Appl Pharmacol 136:307–16
- Catania VA, Dannenberg AJ, Luquita MG, et al. (1995). Gender-related differences in the amount and functional state of rat liver UDP-glucuronosyltransferase. Biochem Pharmacol 50:509–14
- Funk C, Pantze M, Jehle L, et al. (2001). Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology 167:83–98
- Hanano M, Umemura K, Iga T. (1985). Applied Pharmacokinetics - Theory and experiments. Tokyo: Soft Science, Inc
- Higashi Y, Inami M, Ito M, et al. (2012). ASP015K: a novel JAK inhibitor demonstrated potent efficacy in a chronic oxazolone-induced dermatitis model in rats. Abstracts (P093) of the 3rd World Psoriasis & Psoriatic Arthritis Conference 2012: “Psoriasis-a global health challenge”; 2012; Stockholm, Sweden
- Honma W, Shimada M, Sasano H, et al. (2002). Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver. Drug Metab Dispos 30:944–9
- Houston JB. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469–79
- Iwano S, Higashi E, Miyoshi T, et al. (2012). Focused DNA microarray analysis for sex-dependent gene expression of drug metabolizing enzymes, transporters and nuclear receptors in rat livers and kidneys. J Toxicol Sci 36:863–9
- Iwasaki K, Tokuma Y, Noda K, Noguchi H. (1994). Age- and sex-related changes of sulfotransferase activities in the rat. Chem Biol Interact 92:209–17
- Kato R. (1974). Sex-related differences in the drug metabolism. Drug Metab Rev 3:1–32
- Maiti S, Chen G. (2003). Tamoxifen induction of aryl sulfotransferase and hydroxysteroid sulfotransferase in male and female rat liver and intestine. Drug Metab Dispos 31:637–44
- Oda K, Mera K, Nagasaka Y, Tokoro K. (2014). Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC-MS/MS. Biomed Chromatogr (In press). DOI: 10.1002/bmc.3380
- Ogura K, Sohtome T, Sugiyama A, et al. (1990). Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes. Mol Pharmacol 37:848–54
- Rajkowski KM, Robel P, Baulieu EE. (1997). Hydroxysteroid sulfotransferase activity in the rat brain and liver as a function of age and sex. Steroids 62:427–36
- Stern ST, Tallman MN, Miles KK, et al. (2007). Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats. Drug Metab Dispos 35:449–54
- Takeuchi T, Tanaka Y, Iwasaki M, et al. (2014). A phase 2b study of an oral JAK inhibitor ASP015K monotherapy in Japanese patients with moderate to severe rheumatoid arthritis. EULAR; 2014 June 11–14; Paris, France
- Tran C, Knowles SR, Liu BA, Shear NH. (1998). Gender differences in adverse drug reactions. J Clin Pharmacol 38:1003–9
- Wang RH, Schorer-Apelbaum D, Weinstock M. (2001). Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine. Eur J Pharmacol 433:73–9